Differences between revisions 11 and 12
Revision 11 as of 2012-02-23 17:25:00
Size: 1951
Editor: GaryBader
Comment:
Revision 12 as of 2012-02-23 17:26:12
Size: 2039
Editor: GaryBader
Comment:
Deletions are marked like this. Additions are marked like this.
Line 33: Line 33:

https://docs.google.com/document/d/1aCQYxxvAW0mxWejUpS2JX8uqWOlV73l_tzdng3V_nW0/edit

Cytoscape 3 Mini Retreat 2012

Place and time

Thursday, February 23 2011 - 9am-5pm in San Diego (Ideker Lab, La Jolla)

We will be in room 273 of the Medical Teaching Facility on the main UCSD campus.

Attendees:

Focus

Determine what work remains for the 3.0 release.

Agenda

  • Stateless TaskFactory API Background/Proposal

  • Decide on approach for making anonymous (i.e. available only as a service) TaskFactories available as an API so that TaskFactories can be reused easily.

  • Session API/implementation; i.e. does the existing implementation allow us to support future extensions (e.g. groups, multiple network views) without breaking API?
  • API changes necessary for 3.0 in order to support multiple rendering engines in 3.1 without breaking API.
  • Cytoscape App Manager integration with App Store.
  • Decide which layout algorithms to keep/remove for 3.0.
  • Complete GUI/UI review with team to identify missing features
  • Complete public API review. For each public API, assess stability and decide if we need to test it further (e.g. do we need to test the session API more by implementing multiple rendering engines and more CyGroup code)

  • How will Apps work in 3.0?
  • Github vs. SourceForge?

  • Establish a release schedule for 3.0

Lunch agenda items

  • Main retreat—where? when?
  • Discuss testing restore of Cytoscape developer websites (e.g. code.cytoscape.org, wiki.cytoscape.org) from Amazon Cloud in non-Toronto locations.

Results

https://docs.google.com/document/d/1aCQYxxvAW0mxWejUpS2JX8uqWOlV73l_tzdng3V_nW0/edit

Cytoscape_3/MiniRetreat2012 (last edited 2012-02-23 17:26:12 by GaryBader)

Funding for Cytoscape is provided by a federal grant from the U.S. National Institute of General Medical Sciences (NIGMS) of the Na tional Institutes of Health (NIH) under award number GM070743-01. Corporate funding is provided through a contract from Unilever PLC.

MoinMoin Appliance - Powered by TurnKey Linux